Gene · 80149
ZC3H12A: zinc finger CCCH-type containing 12A
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. ZC3H12A: zinc finger CCCH-type containing 12A. Genes, record 80149. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/80149
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q5D1E8 | Endoribonuclease ZC3H12A | 599 | 3 | Ensembl, GeneID, HGNC |
Source UniProt
Patents42
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4641201 A2 | 2025-10-29 | 9472 | Q5D1E8 | Espacenet |
| WO 2025217591 A1 | 2025-10-16 | 65 | Q5D1E8 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 15898 | Q5D1E8 | Espacenet |
| JP 2025524002 A | 2025-07-25 | 16 | Q5D1E8 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 9472 | Q5D1E8 | Espacenet |
| KR 1020250039465 A | 2025-03-20 | 16 | Q5D1E8 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 15898 | Q5D1E8 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 15898 | Q5D1E8 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 15737 | Q5D1E8 | Espacenet |
| JP 2024023699 A | 2024-02-21 | 16 | Q5D1E8 | Espacenet |
1 to 10 of 42
See all 42 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants736
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ZC3H12A papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| R37DE022550 | Host and Fungal Regulation of Type 17 Immunity to Oral Candidiasis | 5 | 2025 |
| ZIABC011176 | Functions of KSHV microRNAs and circular RNAs | 5 | 2025 |
| R01AI140761 | Transcriptional and metabolic heterogeneity in T cell differentiation | 4 | 2025 |
| R01AI131703 | Regulation of T cell memory in tissue immunity | 3 | 2025 |
| R37AI105887 | Metabolic checkpoint in dendritic cell subsets and adaptive immunity | 3 | 2025 |
| P30AR075043 | University of Michigan Skin Biology and Diseases Resource-based Center | 2 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 2 | 2025 |
| P30CA014520 | UW Comprehensive Cancer Center Support | 2 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 2 | 2025 |
1 to 10 of 736Source NIH's project files
See all 736 nih grantsPapers1,426
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The regnase family in autoimmune diseases: a regnase-1-centered perspective on cellular heterogeneity. | Mol Biol Rep | 2026 | 42821208 | PubTator, text mining | PubMed |
| The ribonuclease ZC3H12A stabilizes BRCA1 mRNA in DNA damage response. | Redox Biol | 2026 | 42809925 | PubTator, text mining | PubMed |
| Targeting Regnase-1 in B7-H3-CAR T cells reprograms the tumor microenvironment and enhances antitumor efficacy for osteosarcoma. | Cell Rep Med | 2026 | 42641597 | PubTator, text mining | PubMed |
| RNF213 marks a regulatory T-cell subset associated with ulcerative colitis. | Front Immunol | 2026 | 42519321 | PubTator, text mining | PubMed |
| RNA-Seq Profiling Reveals Transcriptional Changes in Phosphorylation-Site Mutants of Brg1. | Genes Cells | 2026 | 42469951 | PubTator, text mining | PubMed |
| Genomic architecture of IRF4 rearrangements in childhood and adult large B-cell lymphomas. | Blood Adv | 2026 | 42466980 | PubTator, text mining | PubMed |
| Corrigendum to: "The endonuclease MCPIP1 protects against liver cancer development in a sex-dependent manner by modulating β-catenin and CREB1" [JHEP Reports 8 (2026) 101755]. | JHEP Rep | 2026 | 42418958 | PubTator, text mining | PubMed |
| Inositol biosynthesis is inversely regulated by glycolytic activity. | Biochim Biophys Acta Mol Cell Biol Lipids | 2026 | 42242622 | PubTator, text mining | PubMed |
| Integrated transcriptomic profiling of programmed cell death patterns unveils macrophage-hepatocyte crosstalk via THBS1-CD47 axis in hepatic ischemia-reperfusion injury. | Front Immunol | 2026 | 42238567 | PubTator, text mining | PubMed |
| High Regnase-1 Expression Is Associated with an Immunosuppressive Tumor Microenvironment and Aggressive Features in Glioma Patients. | Cancers (Basel) | 2026 | 42193017 | PubTator, text mining | PubMed |
1 to 10 of 1,426
See all 1,426 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/80149
GET https://conductscience.org/api/genes/v1/80149/patents?page=2